Invivyd Files 2025 Proxy Statement
Ticker: IVVD · Form: DEF 14A · Filed: Apr 7, 2025 · CIK: 1832038
| Field | Detail |
|---|---|
| Company | Invivyd, INC. (IVVD) |
| Form Type | DEF 14A |
| Filed Date | Apr 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, governance, shareholder-meeting
TL;DR
Invivyd dropped its 2025 proxy statement, shareholders vote soon.
AI Summary
Invivyd, Inc. filed its definitive proxy statement (DEF 14A) on April 7, 2025, for the fiscal year ending December 31, 2024. The company, formerly known as Adagio Therapeutics, Inc. until November 12, 2020, is headquartered in Waltham, MA. This filing is related to the company's annual meeting and shareholder matters.
Why It Matters
This filing provides shareholders with crucial information regarding the company's governance, executive compensation, and proposals to be voted on at the upcoming annual meeting, impacting their investment decisions.
Risk Assessment
Risk Level: low — This is a routine regulatory filing (DEF 14A) and does not contain new material financial or operational information that would inherently increase risk.
Key Numbers
- 20250407 — Filing Date (Date the definitive proxy statement was filed with the SEC.)
- 2024-12-31 — Fiscal Year End (The period covered by the financial information in the proxy statement.)
Key Players & Entities
- Invivyd, Inc. (company) — Registrant
- Adagio Therapeutics, Inc. (company) — Former company name
- Waltham, MA (location) — Company headquarters
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or definitive proxy statement, is used by companies to solicit shareholder votes on important matters such as the election of directors, executive compensation, and other corporate actions at their annual or special meetings.
When was Invivyd, Inc. formerly known as Adagio Therapeutics, Inc.?
Invivyd, Inc. was formerly known as Adagio Therapeutics, Inc. until November 12, 2020.
What is the filing date of this proxy statement?
This definitive proxy statement was filed on April 7, 2025.
Where is Invivyd, Inc. headquartered?
Invivyd, Inc. is headquartered at 1601 Trapelo Road, Suite 178, Waltham, MA 02451.
What is the SEC file number for Invivyd, Inc.?
The SEC file number for Invivyd, Inc. is 001-40703.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 7, 2025 regarding Invivyd, Inc. (IVVD).